Compare VRTS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRTS | QDEL |
|---|---|---|
| Founded | 1988 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.0M | 1.0B |
| IPO Year | 1995 | 2022 |
| Metric | VRTS | QDEL |
|---|---|---|
| Price | $144.11 | $11.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $158.00 | $28.25 |
| AVG Volume (30 Days) | 73.4K | ★ 2.2M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.68% | N/A |
| EPS Growth | 18.24 | ★ 45.35 |
| EPS | ★ 1.05 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $1.66 | $3.86 |
| P/E Ratio | $134.82 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $121.61 | $9.92 |
| 52 Week High | $214.88 | $35.58 |
| Indicator | VRTS | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 55.56 | 47.70 |
| Support Level | $135.82 | $10.39 |
| Resistance Level | $147.15 | $12.85 |
| Average True Range (ATR) | 5.32 | 0.95 |
| MACD | -0.18 | 0.34 |
| Stochastic Oscillator | 79.01 | 70.14 |
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.